AUD 0.26
(4.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2024 | -35.97 Million AUD | -14.36% |
2023 | -31.45 Million AUD | -27.92% |
2022 | -24.59 Million AUD | -14.81% |
2021 | -21.42 Million AUD | 2.52% |
2020 | -21.97 Million AUD | -238.55% |
2019 | -6.49 Million AUD | -64.87% |
2018 | -3.93 Million AUD | 0.93% |
2017 | -3.97 Million AUD | -399.07% |
2016 | -796.26 Thousand AUD | -472.74% |
2015 | -139.02 Thousand AUD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 FY | -35.97 Million AUD | -14.36% |
2024 Q1 | -7.8 Million AUD | 48.76% |
2024 Q4 | -10.18 Million AUD | 0.0% |
2024 Q2 | -15.6 Million AUD | -100.0% |
2024 Q3 | -10.18 Million AUD | 34.73% |
2023 Q3 | -7.61 Million AUD | 53.09% |
2023 FY | -31.45 Million AUD | -27.92% |
2023 Q1 | -8.11 Million AUD | 33.15% |
2023 Q4 | -15.22 Million AUD | -100.0% |
2023 Q2 | -16.23 Million AUD | -100.0% |
2022 Q1 | -6.22 Million AUD | 24.77% |
2022 Q2 | -12.45 Million AUD | -100.0% |
2022 Q4 | -12.14 Million AUD | -100.0% |
2022 FY | -24.59 Million AUD | -14.81% |
2022 Q3 | -6.07 Million AUD | 51.26% |
2021 Q3 | -4.13 Million AUD | 68.52% |
2021 FY | -21.42 Million AUD | 2.52% |
2021 Q2 | -13.14 Million AUD | -100.0% |
2021 Q1 | -6.57 Million AUD | 60.94% |
2021 Q4 | -8.27 Million AUD | -100.0% |
2020 Q1 | -2.68 Million AUD | -38.83% |
2020 Q3 | -8.3 Million AUD | -54.68% |
2020 Q4 | -16.82 Million AUD | -102.63% |
2020 FY | -21.97 Million AUD | -238.55% |
2020 Q2 | -5.36 Million AUD | -100.0% |
2019 Q4 | -1.93 Million AUD | 0.0% |
2019 Q2 | -1.31 Million AUD | 0.0% |
2019 Q1 | -1.31 Million AUD | 0.0% |
2019 FY | -6.49 Million AUD | -64.87% |
2019 Q3 | -1.93 Million AUD | -47.35% |
2018 FY | -3.93 Million AUD | 0.93% |
2017 FY | -3.97 Million AUD | -399.07% |
2016 FY | -796.26 Thousand AUD | -472.74% |
2015 FY | -139.02 Thousand AUD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Adherium Limited | -10.22 Million AUD | -251.898% |
Aroa Biosurgery Limited | -9.74 Million AUD | -269.078% |
Atomo Diagnostics Limited | -6.84 Million AUD | -425.405% |
Anteris Technologies Ltd | -67.33 Million AUD | 46.566% |
Control Bionics Limited | -5.91 Million AUD | -508.387% |
CardieX Limited | -6.76 Million AUD | -431.807% |
Compumedics Limited | -338 Thousand AUD | -10544.578% |
Cochlear Limited | 356.8 Million AUD | 110.084% |
CleanSpace Holdings Limited | -3.12 Million AUD | -1050.529% |
Cyclopharm Limited | -4.7 Million AUD | -665.372% |
EMVision Medical Devices Ltd | -2.72 Million AUD | -1218.088% |
Nova Eye Medical Limited | -8.79 Million AUD | -309.314% |
HeraMED Limited | -6.78 Million AUD | -430.372% |
Imricor Medical Systems, Inc. | -22.62 Million AUD | -59.015% |
ImpediMed Limited | -19.79 Million AUD | -81.802% |
InhaleRx Limited | -1.44 Million AUD | -2392.856% |
LBT Innovations Limited | -3.74 Million AUD | -861.997% |
Micro-X Limited | -9.76 Million AUD | -268.445% |
Neurotech International Limited | -5.06 Million AUD | -609.743% |
OncoSil Medical Limited | -11.91 Million AUD | -201.996% |
PolyNovo Limited | 5.26 Million AUD | 783.875% |
Respiri Limited | -7.12 Million AUD | -404.663% |
SomnoMed Limited | -12.24 Million AUD | -193.902% |
Universal Biosensors, Inc. | -6.74 Million AUD | -433.684% |
Uscom Limited | -2.07 Million AUD | -1634.122% |
Visioneering Technologies, Inc. | -5.06 Million AUD | -610.577% |